Vir Biotechnology annual meeting: directors elected, say-on-pay and auditor ratified

Vir Biotechnology, Inc.

Stockholders elected Robert More, Janet Napolitano, Vicki Sato, and Elliott Sigal as Class I directors; each received over 98M votes for.
Advisory vote on executive compensation approved: 106.0M for, 4.4M against, 97K abstentions, 8.3M broker non-votes.
Ratification of Ernst & Young as independent auditor for FY2023 approved: 118.7M for, 41.7K against, 109.8K abstentions.

item 5.07

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.99

Vir Biotechnology, Inc. shareholders approved Election of four Class I Directors at the 2023-05-19 meeting.

Proposal: director election
Outcome: passed
Meeting: 2023-05-19

Exact text from the filing

Proposal 1. Election of Directors The Company’s stockholders elected the four persons listed below as Class I Directors

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.99

Vir Biotechnology, Inc. shareholders approved Advisory Vote on Executive Compensation at the 2023-05-19 meeting.

Proposal: say on pay
Outcome: passed
Meeting: 2023-05-19

Exact text from the filing

Proposal 2. Advisory Vote on Executive Compensation The Company’s stockholders approved, on an advisory basis, the compensation of the Company’s named executive officers.

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.99

Vir Biotechnology, Inc. shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm at the 2023-05-19 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2023-05-19

Exact text from the filing

Proposal 3. Ratification of Appointment of Independent Registered Public Accounting Firm The Company’s stockholders ratified the appointment by the Audit Committee

View on SEC.gov

160 shareholder votes filed in the last 30 days. Browse all shareholder votes →

Vir Biotechnology, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-23-023627

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.